C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) C07K 14/705 (2006.01) C07K 14/72 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01) G01N 33/566 (2006.01) G01N 33/68 (2006.01) G01N 33/74 (2006.01)
Patent
CA 2193685
This invention provides methods for screening for agents useful for treatment of diseases and pathological conditions affected by the level of NUC protein activity. These agents reduce or relieve the repression of PPAR.alpha. protein and TR protein transcription activation activity by NUC protein. The selected novel or unique agents can be used to treat hyperlipidemia, hypercholesteremia and hyperlipoproteinemia.
L'invention concerne des méthodes de criblage d'agents utilisés pour le traitement de maladies et d'états pathologiques affectés par le niveau d'activité de la protéine NUC. Ces agents réduisent ou atténuent la répression de l'activité d'activation transcriptionnelle de la protéine PPAR.alpha. et de la protéine TR par la protéine NUC. Ces agents nouveaux ou uniques, sélectionnés, peuvent être utilisés pour traiter l'hyperlipidémie, l'hypercholestérolémie et l'hyperlipoprotéinémie.
Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated
Smart & Biggar
LandOfFree
Screening for nuc inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening for nuc inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening for nuc inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1404999